How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice.
Arch Ital Urol Androl
; 94(3): 369-370, 2022 Sep 26.
Article
en En
| MEDLINE
| ID: mdl-36165488
To the Editor, The exact time to stop bladder cancer patient's follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Vejiga Urinaria
Límite:
Humans
Idioma:
En
Revista:
Arch Ital Urol Androl
Asunto de la revista:
MEDICINA REPRODUTIVA
/
NEFROLOGIA
/
UROLOGIA
Año:
2022
Tipo del documento:
Article
Pais de publicación:
Italia